Femasys INC Form 4 insider transactions

Femasys Inc.'s Chief Operating Officer, Daniel Scott Currie, was granted stock options on January 28, 2025, which vest over three and four years.

Christine E. Thomas, Chief Regulatory and Clinical Officer at Femasys Inc., was granted stock options on January 28, 2025.

Femasys Inc.'s Chief Financial Officer, Dov Elefant, acquired stock options for 186,345 shares of common stock on January 28, 2025.

Femasys CEO Kathy Lee-Sepsick was granted stock options for a total of 442,902 shares, vesting over three and four years.

Director Joshua Silverman acquired 17,600 stock options in Femasys Inc. on July 12, 2024.

Director Charles Larsen acquired 17,600 stock options in Femasys Inc. on July 12, 2024.

Director Alistair Milnes reports the acquisition of stock options in Femasys Inc.

Director Edward R Uzialko of Femasys Inc. reports acquiring 17,600 stock options on July 12, 2024.